Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer

Acad Radiol. 1996 Apr;3 Suppl 1:S24-7. doi: 10.1016/s1076-6332(96)80472-7.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Magnetic Resonance Imaging / economics*
  • Male
  • Models, Economic
  • Neoplasm Staging / economics
  • Prostate / pathology
  • Prostatic Neoplasms / economics*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Quality-Adjusted Life Years
  • Sensitivity and Specificity
  • Survival Rate